Lippman SM - Search Results

1

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM. Shureiqi I, et al. Among authors: lippman sm. Cancer Res. 2000 Dec 15;60(24):6846-50. Cancer Res. 2000. PMID: 11156377

2

Determination of biomarkers for intermediate end points in chemoprevention trials.

Lee JS, Lippman SM, Hong WK, Ro JY, Kim SY, Lotan R, Hittelman WN. Lee JS, et al. Among authors: lippman sm. Cancer Res. 1992 May 1;52(9 Suppl):2707s-2710s. Cancer Res. 1992. PMID: 1348662 Review.

3

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: lippman sm. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

4

Recent advances in cancer chemoprevention.

Lippman SM, Hittelman WN, Lotan R, Pastorino U, Hong WK. Lippman SM, et al. Cancer Cells. 1991 Feb;3(2):59-65. Cancer Cells. 1991. PMID: 1674206

5

Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.

Lippman SM, Toth BB, Batsakis JG, Weber RS, McCarthy KS, Hays GL, Wargovich MJ, Lee JS, Thacher S, Lotan R, et al. Lippman SM, et al. Prog Clin Biol Res. 1990;339:179-91. Prog Clin Biol Res. 1990. PMID: 1697415 No abstract available.

6

Biomarkers as intermediate end points in chemoprevention trials.

Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 1990 Apr 4;82(7):555-60. doi: 10.1093/jnci/82.7.555. J Natl Cancer Inst. 1990. PMID: 2179569 Review. No abstract available.

7

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Hong WK, et al. Among authors: lippman sm. N Engl J Med. 1990 Sep 20;323(12):795-801. doi: 10.1056/NEJM199009203231205. N Engl J Med. 1990. PMID: 2202902 Free article. Clinical Trial.

8

Chemoprevention of upper aerodigestive tract cancers: a report of the third Upper Aerodigestive Cancer Task Force workshop.

Lippman SM, Lee JS, Lotan R, Hong WK. Lippman SM, et al. Head Neck. 1990 Jan-Feb;12(1):5-20. doi: 10.1002/hed.2880120103. Head Neck. 1990. PMID: 2404905 Review.

9

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Xu XC, et al. Among authors: lippman sm. Cancer Res. 1995 Dec 1;55(23):5507-11. Cancer Res. 1995. PMID: 7585623

10

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Lotan R, et al. Among authors: lippman sm. N Engl J Med. 1995 May 25;332(21):1405-10. doi: 10.1056/NEJM199505253322103. N Engl J Med. 1995. PMID: 7723796 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters